SecBot SecBot
S-3 ·Filed Mar 17, 2026

ATRA

Atara Biotherapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonimmediate Processed8mo ago SEC0001193125-26-110849
Shelf registration, potential dilution
Actionable Insight • Neutral

Monitor for HCR Molag's potential sale of up to 400,000 shares which could create downward pressure on stock price. The minimal proceeds to Atara ($40) suggest this is not a capital raise but rather facilitating an investor exit. Watch for warrant exercise which would provide nominal cash but increase share count.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$5.00
T+0 close · Mar 17, 2026 · via day close
Latest settled
+109.20%
T+60 · $10.46
Vs SPY
+97.67%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 18 $5.00entry
  2. T+1 · 8mo ago +2.40%α +2.67% · $5.12
  3. T+5 · 8mo ago −0.80%α −0.09% · $4.96
  4. T+20 · 7mo ago +4.80%α −1.25% · $5.24
  5. T+60 · 5mo ago +109.20%α +97.67% · $10.46
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Atara Biotherapeutics has filed an S-3 shelf registration to register 400,000 shares of common stock for resale by HCR Molag Fund, L.P., a selling stockholder. These shares are issuable upon exercise of a warrant granted in connection with an amendment to a purchase agreement that extended the due date of a $9.0 million milestone payment from June 2026 to January 2028. Atara will not receive proceeds from the resale, but may receive $0.04 from the warrant exercise. The offering represents a 4.9% dilution based on current market cap.

Key Financial Metrics

Offering Size
$2.4M
Dilution
4.9%

Key Facts

  • S-3 filing registers 400,000 shares for resale by HCR Molag Fund, L.P.
  • Shares are issuable upon exercise of a warrant with $0.0001 exercise price.
  • Warrant was issued in connection with extending a $9.0 million milestone payment due date from June 2026 to January 2028.
  • Atara will not receive proceeds from the resale of shares by the selling stockholder.
  • Atara may receive $40 from warrant exercise (400,000 shares × $0.0001).
  • Offering represents 4.9% of current shares outstanding (8.178M).
  • Current market cap is $42M with stock price at $6.50.

Financial Impact

Potential $40 in proceeds to Atara from warrant exercise; 4.9% potential dilution from resale

dilutioncashFlow

Risk Factors

  • Potential stock price pressure from HCR Molag selling up to 400,000 shares
  • Dilution of existing shareholders if warrant is exercised and shares are sold
  • Market perception of insider selling despite being a contractual obligation

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001193125-26-110849
Document: d100379dexfilingfees.htm0001193125-26-110849
Document: d100379dex51.htm0001193125-26-110849
Document: d100379dex231.htm0001193125-26-110849
Document: 0001193125-26-110849-index-headers.html0001193125-26-110849
Document: 0001193125-26-110849-index.html0001193125-26-110849
Document: 0001193125-26-110849.txt0001193125-26-110849
CONTEXT: 10-Q (2025-11-12)0001193125-25-276219

Track record

11 reports on ATRA

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago S-3 Bearish 5/10 Entry $8.23 to $7.93 Now $6.40 +22.24% ▲ +3.65% +3.29% vs SPY
  2. Nov 10, 20266d ago 8-K Neutral 5/10 Entry $8.23 to $7.93 Now $6.40 −22.24% ▼ −3.65% −3.29% vs SPY
  3. Jun 26, 202620w ago 8-K Neutral 3/10 Entry $11.17 to $11.48 Now $6.40 −42.70% ▲ +2.78% +2.00% vs SPY
  4. Jun 15, 202622w ago 3 Neutral 2/10 Entry $9.62 to $9.67 Now $6.40 −33.47% ▲ +0.52% +1.77% vs SPY
  5. May 7, 202627w ago 8-K Neutral 4/10 Entry $9.93 to $8.34 Now $6.40 −35.55% ▼ −16.01% −16.84% vs SPY
  6. May 7, 202627w ago Insider Cluster Mixed 5/10 Entry $9.93 to $8.34 Now $6.40 −35.55% ▼ −16.01% −16.84% vs SPY
  7. Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $4.99 to $4.73 Now $6.40 +28.26% ▼ −5.21% −4.73% vs SPY
  8. Mar 17, 202634w ago S-3 Neutral 4/10 Viewing Entry $5.00 to $5.12 Now $6.40 +28.00% ▲ +2.40% +2.67% vs SPY
  9. Mar 12, 202635w ago 8-K Neutral 5/10 Entry $6.90 to $6.50 Now $6.40 −7.25% ▼ −5.80% −5.20% vs SPY
  10. Mar 3, 202636w ago 8-K Mixed 6/10 Entry $5.42 to $5.39 Now $6.40 +18.08% ▼ −0.55% −1.31% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 6h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 17, 2026